myNEO Therapeutics pitches at the semi finals of EIT Health Catapult
2 November 2021

EIT Health Catapult provides investors and industry representatives an excellent opportunity to gain access to a concentrated elite group of top European start-up companies keen to collaborate with strong partners, when they take their first steps towards economic value creation. Top start-up companies from all over Europe are pitching in front of a hand-picked jury consisting of healthcare professionals with various fields of expertise after 2 days of intense mentoring and business model optimization.  

In total, 42 companies in biotech, medtech, and digital health have been selected for the semi-finals to pitch in front of a jury and audience of market experts and investors. Bert Coessens (COO myNEO Therapeutics) will pitch for myNEO Therapeutics in the semifinals on 1-3 December.